[Pemphigus: Towards a drastic reduction in corticosteroid therapy thanks to rituximab].
暂无分享，去创建一个
[1] L. Misery,et al. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial , 2017, The Lancet.
[2] J. Roujeau,et al. Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response , 2013, Science Translational Medicine.
[3] E. Hodak,et al. Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients. , 2013, Journal of the American Academy of Dermatology.
[4] R. Corona,et al. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up. , 2012, Journal of the American Academy of Dermatology.
[5] J. Roujeau,et al. A single cycle of rituximab for the treatment of severe pemphigus. , 2007, The New England journal of medicine.
[6] L. Cavacini,et al. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. , 2006, The New England journal of medicine.
[7] Masayuki Amagai,et al. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion , 1991, Cell.
[8] J. Stanley. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. , 1989, The Journal of clinical investigation.